Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrew Hendifar

Showing results (81-90 of 89) with videos related to

Pageof 9
Sort By:
You have reached the last page of results.This site can display upto 89 results.
JCO Precision Oncology|October 5, 2020
Identification of Actionable Fusions as an Anti-EGFR Resistance Mechanism Using a Circulating Tumor DNA AssayKatherine Clifton, Thereasa A Rich, Christine Parseghian, et al.
The New England Journal of Medicine|October 22, 2025
Belzutifan for Advanced Pheochromocytoma or ParagangliomaCamilo Jimenez, Mikkel Andreassen, Alice Durand, et al.
Liver Cancer|October 9, 2025
Curative Treatment after Immunotherapy Leads to Excellent Outcomes in Patients with Hepatocellular CarcinomaGwang Hyeon Choi, Hyun-Seok Kim, Michael Luu, et al.
Hepatology Communications|June 19, 2024
Development and validation of a biomarker index for HCC treatment responseJeff Liang, Po-Yi Li, Joshua Norman, et al.
Journal of Translational Medicine|May 10, 2024
Keratin 17 modulates the immune topography of pancreatic cancerLyanne Delgado-Coka, Michael Horowitz, Mariana Torrente-Goncalves, et al.
Research Square|March 11, 2024
Keratin 17 modulates the immune topography of pancreatic cancerLyanne A Delgado-Coka, Michael Horowitz, Mariana Torrente-Goncalves, et al.
The New England Journal of Medicine|January 12, 2017
Phase 3 Trial of <sup>177</sup>Lu-Dotatate for Midgut Neuroendocrine TumorsJonathan Strosberg, Ghassan El-Haddad, Edward Wolin, et al.
European Journal of Nuclear Medicine and Molecular Imaging|March 4, 2020
Impact of liver tumour burden, alkaline phosphatase elevation, and target lesion size on treatment outcomes with <sup>177</sup>Lu-Dotatate: an analysis of the NETTER-1 studyJonathan Strosberg, Pamela L Kunz, Andrew Hendifar, et al.
Cancers|August 7, 2021
Clinical Characteristics and Outcomes of Colorectal Cancer in the ColoCare Study: Differences by Age of OnsetCaroline Himbert, Jane C Figueiredo, David Shibata, et al.
Pageof 9

Showing results (81-90 of 89) with videos related to

Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 89 results.
JCO Precision Oncology|October 5, 2020
Identification of Actionable Fusions as an Anti-EGFR Resistance Mechanism Using a Circulating Tumor DNA AssayKatherine Clifton, Thereasa A Rich, Christine Parseghian, et al.
The New England Journal of Medicine|October 22, 2025
Belzutifan for Advanced Pheochromocytoma or ParagangliomaCamilo Jimenez, Mikkel Andreassen, Alice Durand, et al.
Liver Cancer|October 9, 2025
Curative Treatment after Immunotherapy Leads to Excellent Outcomes in Patients with Hepatocellular CarcinomaGwang Hyeon Choi, Hyun-Seok Kim, Michael Luu, et al.
Hepatology Communications|June 19, 2024
Development and validation of a biomarker index for HCC treatment responseJeff Liang, Po-Yi Li, Joshua Norman, et al.
Journal of Translational Medicine|May 10, 2024
Keratin 17 modulates the immune topography of pancreatic cancerLyanne Delgado-Coka, Michael Horowitz, Mariana Torrente-Goncalves, et al.
Research Square|March 11, 2024
Keratin 17 modulates the immune topography of pancreatic cancerLyanne A Delgado-Coka, Michael Horowitz, Mariana Torrente-Goncalves, et al.
The New England Journal of Medicine|January 12, 2017
Phase 3 Trial of <sup>177</sup>Lu-Dotatate for Midgut Neuroendocrine TumorsJonathan Strosberg, Ghassan El-Haddad, Edward Wolin, et al.
European Journal of Nuclear Medicine and Molecular Imaging|March 4, 2020
Impact of liver tumour burden, alkaline phosphatase elevation, and target lesion size on treatment outcomes with <sup>177</sup>Lu-Dotatate: an analysis of the NETTER-1 studyJonathan Strosberg, Pamela L Kunz, Andrew Hendifar, et al.
Cancers|August 7, 2021
Clinical Characteristics and Outcomes of Colorectal Cancer in the ColoCare Study: Differences by Age of OnsetCaroline Himbert, Jane C Figueiredo, David Shibata, et al.
Pageof 9